Friday, July 10, 2020

Plant- Microbial fuel cell: Generating electricity from green, living plants

This article is by

Share this article

Article Contributor(s)

Charvi Trivedi

Article Title

Plant- Microbial fuel cell: Generating electricity from green, living plants

Publisher

Global Views 360

Publication Date

July 10, 2020

URL

Marshland near Blythburgh. View over the tidal River Blyth

Marshland near Blythburgh. View over the tidal River Blyth  | Source:  Eileen Henderson via Wikimedia

Humans are capable of discovering and creating great things with the help of science and one such impressive discovery is that green, living plants can generate electricity. It may seem unbelievable, but not impossible.

One must be wondering how this technology works. Well, the answer is quite simple; photosynthesis. Plants excrete organic matter into the soil as a result of photosynthesis. Only some of the organic matter is used by plants and the rest is released in the soil. This released organic matter is broken down by bacteria. In the breakdown process, electrons are released as a waste product. Since the movement of electrons produces electricity, these electrons, which are of no use to the plant, can be harvested. The best part about this innovation is that the plants from which energy is being generated are not affected in any way.

This idea was first put into use by a Dutch start-up called Plant-e. This company was launched in September 2009 and is successful in launching and selling many environment- friendly products like DIY kits to the public for experimentation purposes and modular systems which could be easily installed on green roofs for abundant electricity production. Plant-e is involved in various projects, within The Netherlands, like automatic lighting systems in gardens and many more.

This technology works with the plants which thrive in moist soils and where the water is present in abundance. Therefore marshlands, paddy fields and deltas are some of the most suitable places for setting up plant batteries as a huge amount of water is present in those areas. Hence, the use of this technology is limited to certain geographic areas containing moist soils and cannot be used in arid regions. It may, however, promote the growth of more trees and plants which will gradually reverse the malicious effects of global warming.

Another obstacle in widespread adoption of this technology in today’s time is the high cost of installation of the system. The initial adopters of this technology are those who are attracted by the efficiency and eco-friendly nature of the plant batteries and willing to pay a premium for it.

The concept of plant batteries can be further taken into rural areas where most of the population still does not have access to adequate electricity. It is estimated that plant-MFC technology can cover upto 20% of European Union’s primary future electricity needs. Also, plants are almost 100% efficient at converting photons from sunlight into electrons which indicates a bright future for this technology. However, more research needs to be done in this field.

Another innovation in the field of green electricity is using algae , which often grows in ponds and rivers, for generating electricity. The basic concept which explains the working is similar to the way plants are able to produce electricity; photosynthesis.

Various other ventures in the field of renewable energy also include vegetable batteries, meaning, electric power generated from fruits and vegetables like lemons, tomatoes and potatoes, have been investigated. According to experiments, at least 3 to 4 vegetables are required just to light a small LED bulb. Moreover, it leads to poisoning of the vegetables and those food products need to be thrown away, without being useful for consumption purposes. It is therefore not a viable option for energy production.

Plant based electricity generation is still an evolving technology which has immense potential for producing energy in an environmentally sustainable way. It will realise full potential when the installation cost is attractive enough for the farmers to prefer it over the electricity grids or fossil fuel based personal electricity generator sets.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More